Advertisement
Letters to the Editor| Volume 177, ISSUE 1, P6-7, November 15, 2014

Download started.

Ok

Role of hypocalcemia in identification of 22q11 deletion syndrome among patients with congenital heart defects

Published:October 03, 2014DOI:https://doi.org/10.1016/j.ijcard.2014.09.133
      The 22q11 deletion syndrome (22q11DS), or Velocardiofacial syndrome, is a common genetic disease caused by deficiency on region 11 on the long arm of chromosome 22. Most patients (>90%) show a microdeletion usually detectable through fluorescent in situ hybridization (FISH). Currently, over 180 different findings were described, including physical, psychological and behavioral abnormalities [
      • Rosa R.M.
      • Zen P.G.
      • Roman T.
      • Graziadio C.
      • Paskulin G.A.
      Síndrome de deleção 22q11.2: compreendendo o CATCH22.
      ]. 22q11DS is the second most known cause of congenital heart disease (CHD) [
      • Rosa R.F.M.
      • Zen P.R.G.
      • Graziadio C.
      • Paskulin G.A.
      22q11.2 deletion syndrome and congenital heart defects.
      ]. However, due to difficulties in clinical diagnosis and recognition of 22q11DS, as well as high costs related to diagnostic techniques such as FISH, different screening methods have been suggested in populations with CHD. However, their practical application has been proven non-effective [
      • Rosa R.F.
      • Rosa R.
      • Trevisan P.
      • et al.
      Screening for 22q11 deletion syndrome among patients with congenital heart defects.
      ].

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to International Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Rosa R.M.
        • Zen P.G.
        • Roman T.
        • Graziadio C.
        • Paskulin G.A.
        Síndrome de deleção 22q11.2: compreendendo o CATCH22.
        Rev Paul Pediatr. 2009; 27: 211-220
        • Rosa R.F.M.
        • Zen P.R.G.
        • Graziadio C.
        • Paskulin G.A.
        22q11.2 deletion syndrome and congenital heart defects.
        Rev Paul Pediatr. 2011; 29: 251-260
        • Rosa R.F.
        • Rosa R.
        • Trevisan P.
        • et al.
        Screening for 22q11 deletion syndrome among patients with congenital heart defects.
        Sao Paulo Med J. 2014; 132: 125-126
        • Cancrini C.
        • Puliafito P.
        • Digilio M.C.
        • et al.
        Clinical features and follow-up in patients with 22q11.2 deletion syndrome.
        J Pediatr. 2014; 164 ([e2]): 1475-1480
        • Rosa R.F.M.
        • Pilla C.B.
        • Pereira V.L.B.
        • et al.
        22q11.2 deletion syndrome in patients admitted to a cardiac pediatric intensive care unit in Brazil.
        Am J Med Genet A. 2008; 146A: 1655-1656
        • Agergaard P.
        • Olesen C.
        • Ostergaard J.R.
        • Christiansen M.
        • Sorensen K.M.
        The prevalence of chromosome 22q11.2 deletions in 2478 children with cardiovascular malformations. A population-based study.
        Am J Med Genet A. 2012; 158A: 498-508
        • Repetto G.M.
        • Guzmán M.L.
        • Puga A.
        • et al.
        Clinical features of chromosome 22q11.2 microdeletion syndrome in 208 Chilean patients.
        Clin Genet. 2009; 76: 465-470
        • Cheung E.N.
        • George S.R.
        • Costain G.A.
        • et al.
        Prevalence of hypocalcemia and its associated features in 22q11.2 deletion syndrome.
        Clin Endocrinol. 2014; 81 ([Oxf]): 190-196
        • Lima K.
        • Abrahamsen T.G.
        • Wolff A.B.
        • et al.
        Hypoparathyroidism and autoimmunity in the 22q11.2 deletion syndrome.
        Eur J Endocrinol. 2011; 165: 345-352
        • Rosa R.F.
        • Rosa R.
        • Krumenauer R.C.
        • Varella-Garcia M.
        • Paskulin G.A.
        Anterior laryngeal membrane and 22q11 deletion syndrome.
        Braz J Otorhinolaryngol. 2011; 77: 540